NDC 68462-435

Acamprosate Calcium 333 mg tablet, delayed release

On the label: Glenmark Pharmaceuticals Inc., USA.

India: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Glenmark Pharmaceuticals LimitedGoa, IndiaMakes it and tests it Problems found, fixed voluntarilyJun 30, 2026 · 7 inspections, 1 with FDA action

Product details

Generic drug
Acamprosate: every company that makes it
Form
tablet, delayed release, oral
Strength
333 mg
Approval
ANDA ANDA202229
On the market since
Jul 16, 2013
Package NDCs
68462-435-11 68462-435-18
Official label
DailyMed (National Library of Medicine), updated Jan 23, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?